Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial.
Denda T, Takashima A, Gamoh M, Iwanaga I, Komatsu Y, Takahashi M, Nakamura M, Ohori H, Sakashita A, Tsuda M, Kobayashi Y, Baba H, Kotake M, Ishioka C, Yamada Y, Sato A, Yuki S, Morita S, Takahashi S, Yamaguchi T, Shimada K. Denda T, et al. Among authors: yamaguchi t. Eur J Cancer. 2021 Sep;154:296-306. doi: 10.1016/j.ejca.2021.06.013. Epub 2021 Jul 22. Eur J Cancer. 2021. PMID: 34304054 Free article. Clinical Trial.
[Surgery for colorectal cancer in elderly patients].
Takahashi K, Matsumoto H, Yamaguchi T, Nakano D, Watanabe F, Oohinata R, Iwanaga T, Oohashi M, Iwasaki Y. Takahashi K, et al. Among authors: yamaguchi t. Gan To Kagaku Ryoho. 2010 Dec;37(13):2823-8. Gan To Kagaku Ryoho. 2010. PMID: 21160257 Review. Japanese.
A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study).
Hamamoto Y, Yamaguchi T, Nishina T, Yamazaki K, Ura T, Nakajima T, Goto A, Shimada K, Nakayama N, Sakamoto J, Morita S, Yamada Y. Hamamoto Y, et al. Among authors: yamaguchi t. Oncologist. 2014 Nov;19(11):1131-2. doi: 10.1634/theoncologist.2014-0159. Epub 2014 Oct 3. Oncologist. 2014. PMID: 25280489 Free PMC article. Clinical Trial.
Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.
Yamaguchi T, Furukawa Y, Nakamura Y, Matsubara N, Ishikawa H, Arai M, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Moriya Y, Ishida H, Watanabe T, Sugihara K; HNPCC Registry and Genetic Testing Project of the Japanese Society for Cancer of the Colon and Rectum. Yamaguchi T, et al. Jpn J Clin Oncol. 2015 Feb;45(2):153-9. doi: 10.1093/jjco/hyu190. Epub 2014 Nov 17. Jpn J Clin Oncol. 2015. PMID: 25404568
S-1 and irinotecan with or without bevacizumab versus 5-fluorouracil and leucovorin plus oxaliplatin with or without bevacizumab in metastatic colorectal cancer: a pooled analysis of four phase II studies.
Iwasa S, Nagashima K, Yamaguchi T, Matsumoto H, Ichikawa Y, Goto A, Yasui H, Kato K, Okita NT, Shimada Y, Yamada Y. Iwasa S, et al. Among authors: yamaguchi t. Cancer Chemother Pharmacol. 2015 Sep;76(3):605-14. doi: 10.1007/s00280-015-2834-4. Epub 2015 Jul 29. Cancer Chemother Pharmacol. 2015. PMID: 26220845 Clinical Trial.
9,115 results